The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Barclays? What do they know?
"BARCLAYS Q1 PROFITS FALL 12% AS MORTGAGE DEMAND SUBDUED
(Sharecast News) - Barclays Bank reported a 12% fall in first-quarter profit on lower income as customers shopped around for better savings rates and mortgage deals.
Pre-tax profit for the first three months of the year fell to £2.2bn from £2.6bn a year earlier and slightly better than its own consensus forecast of £2.195bn.
Loans and advances to customers fell by 1%, "reflecting subdued mortgage lending amid lower market demand", the bank added, while deposits were fell 2% as savers chased better rates elsewhere after years of paltry returns.
Group income fell 4% to £7bn, while net interest margin - the difference between what the bank charges for loans and savings - fell to 3.09% from 3.18%.
Income at its investment division fell 7% to £3.32bn after a strong performance in equities was more than offset by lower fixed income trading and weaker merger advisory fees.
Loan default impairments fell to £58m, compared with £113m last year.
Reporting by Frank Prenesti for Sharecast.com
So that's why it has dropped.
Sold roughly one third. I also have AV. which sank by more than the % dividend, so I can now buy these if LGEN doesn't do likewise. Or maybe something else, but I have cash and have already made a profit, which is nice.
If like me you held on for the dividend, it will be paid in May. Then, if the stock continues to be a bargain, as it is now, you can reinvest your divi and get more shares than you would if it hadn't dipped. Or maybe the price will have recovered...
As usual it is impossible to forecast.
Unfortunately your woeful description does not match up to the company in which I was an investor for several years. Stadium performance netted me far more profits than TTG has succeeded in doing so far.
Virolens came after the acquisition of 2018 because of course it was a COVID product and was developed by iabra. What has it to do with Stadium?
On the positive side, my investment in POLR is now reaping me dividends and the company's success is said to indicate an upturn in tech interest generally. I hope TTG will also benefit.
Once I would have held onto this stock because I hate to realise losses and legal difficulties often get resolved with less impact than first thought. However, in this case I bailed out because I could invest my reduced capital in stock that were low for no good reason thanks to the under-appreciated London market. They were at 4451 on that day and of course my new investment has been pretty static, but at least it hasn't dropped! At some point I might return to RKT.
"What was so bad about the Stadium deal?
"[Stadium] pumped around £2m into its Hartlepool site over the last two years to create what officials describe as a European manufacturing centre of excellence." 16 Feb 2018
https://www.thenorthernecho.co.uk/business/15996227.tt-electronics-makes-move-hartlepool-based-stadium-group/
"
You never did answer my question HogBog!